ARCHIVES

Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 36 No. 5 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

CCOP RFA Response So Far Points To More Consortia Applications, Reasonable Geographic Distribution

August 20, 1982

Cooperative Groups Should Be Trimmed, Brought Under Control Of DCT, Surgical Panel Suggests

May 31, 1974

UPCI wins NCI SPORE grant for head and neck cancer.

September 24, 2004

GAO Criticize NCI Contract Practices In Report On Cancer Control

July 25, 1980

NCCS Networker Volume 1 Issue 3, Fall 1987

September 13, 1987

ASCO Highlights Seven of 4,000 Abstracts Submitted for Annual Meeting, June 3-7

May 27, 2011